Smart-Money SignalNeutral · 45/100— Insiders are net sellers over 90 days (-$293K, 2 sales vs 1 buy)
Revenue$766.2M
Net Income$105.5M
EPS$0.54
Market Cap$11.5B
Price Performance
Historical data including institutional events
Company Profile
A
Alexander Hardy
CEO & Executive Director
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).
